These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12432277)

  • 1. p53 Antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20.
    Jabbur JR; Zhang W
    Cancer Biol Ther; 2002; 1(3):277-83. PubMed ID: 12432277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdm-2 binding and TAF(II)31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21.
    Jabbur JR; Tabor AD; Cheng X; Wang H; Uesugi M; Lozano G; Zhang W
    Oncogene; 2002 Oct; 21(46):7100-13. PubMed ID: 12370832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the antiproliferative function of p53 by phosphorylation at serine 20: an inference from site-directed mutagenesis studies.
    Jabbur JR; Huang P; Zhang W
    Int J Mol Med; 2001 Feb; 7(2):163-8. PubMed ID: 11172619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Induction: phosphorylation sites cooperate in regulating.
    Meek DW
    Cancer Biol Ther; 2002; 1(3):284-6. PubMed ID: 12432278
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo.
    Jabbur JR; Huang P; Zhang W
    Oncogene; 2000 Dec; 19(54):6203-8. PubMed ID: 11175334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study.
    Lee HJ; Srinivasan D; Coomber D; Lane DP; Verma CS
    Cell Cycle; 2007 Nov; 6(21):2604-11. PubMed ID: 17957142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
    Dumaz N; Meek DW
    EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
    Unger T; Juven-Gershon T; Moallem E; Berger M; Vogt Sionov R; Lozano G; Oren M; Haupt Y
    EMBO J; 1999 Apr; 18(7):1805-14. PubMed ID: 10202144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300.
    Dornan D; Hupp TR
    EMBO Rep; 2001 Feb; 2(2):139-44. PubMed ID: 11258706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
    Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel p53 mutant retained functional activity in lung carcinomas.
    Ko JL; Chiao MC; Chang SL; Lin P; Lin JC; Sheu GT; Lee H
    DNA Repair (Amst); 2002 Sep; 1(9):755-62. PubMed ID: 12509279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatinum and taxol induce different patterns of p53 phosphorylation.
    Damia G; Filiberti L; Vikhanskaya F; Carrassa L; Taya Y; D'incalci M; Broggini M
    Neoplasia; 2001; 3(1):10-6. PubMed ID: 11326311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
    Venot C; Maratrat M; Dureuil C; Conseiller E; Bracco L; Debussche L
    EMBO J; 1998 Aug; 17(16):4668-79. PubMed ID: 9707426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
    Dumaz N; Milne DM; Jardine LJ; Meek DW
    Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.